Khemla, Supphachoke, Atibordee Meesing, Wantin Sribenjalux, and Ploenchan Chetchotisakd. 2023. “Lipid Profiles of People With Human Immunodeficiency Virus With Dyslipidemia After Switching from Efavirenz to Dolutegravir”. Drug Target Insights 17 (1). Milan, Italy:45-53. https://doi.org/10.33393/dti.2023.2529.